SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin
Status:
Completed
Trial end date:
2010-01-26
Target enrollment:
Participant gender:
Summary
It will be an open-label, randomized, laboratory-blind, crossover study with 02 treatments,
02 sequences, and 02 periods, in which the healthy male volunteers under fasting conditions
receive, in each period, the test formulation or the reference formulation